{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/sinusitis/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"6c331f3e-5cee-537d-9ff6-41dba5324ae1","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field 05c521cb-5ccf-4fce-9dcc-a8e700a252b7 --><h2>How common is it?</h2><!-- end field 05c521cb-5ccf-4fce-9dcc-a8e700a252b7 -->","summary":"","htmlStringContent":"<!-- begin item e047df90-331e-4cf1-b91d-a8e700a2503a --><!-- begin field 3c1b929f-5801-4011-bd9d-a8e700a252b7 --><ul><li><strong>Information is limited on the UK prevalence of sinusitis,</strong> although a community-based survey estimated that 25% of the population studied were likely to have sinusitis based on paranasal morbidity scores [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Sami et al, 2018</a>]. </li><li><strong>Acute sinusitis</strong><ul><li>Acute sinusitis is common in adults, with an estimated prevalence of 6–15% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Bird et al, 2013</a>]. </li><li>Around 1–2 in 100 European visits to a GP are thought to be due to symptoms of acute sinusitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Foden et al, 2013</a>].  </li><li>Acute sinusitis can affect any age group, but is less common in children because their sinuses are not fully developed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Foden et al, 2013</a>]. It has been reported that around 6–7% of children presenting with respiratory symptoms have features consistent with a definition of acute sinusitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Wald et al, 2013</a>]. </li></ul></li><li><strong>Chronic sinusitis</strong><ul><li>Chronic sinusitis is a common condition, affecting 1 in 10 UK adults [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">ENT UK and Royal College of Surgeons, 2016</a>]. Data from questionnaire-based studies suggests a prevalence of 4.5–12% in North American and European populations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">DeConde and Soler, 2016</a>].</li><li>Its prevalence increases with age, and it is more likely to occur in women, and in people with asthma, chronic obstructive pulmonary disease, or a history of allergy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Kaplan, 2013</a>]. <strong> </strong></li><li>Paediatric chronic rhinosinusitis is commonly found by ear, nose and throat specialists and may occur as a result of a viral upper respiratory tract infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Brietzke et al, 2014</a>].  </li></ul></li></ul><!-- end field 3c1b929f-5801-4011-bd9d-a8e700a252b7 --><!-- end item e047df90-331e-4cf1-b91d-a8e700a2503a -->","topic":{"id":"6d2333af-675d-5bf3-8f7d-21404b5f0aa9","topicId":"251eec02-9620-4893-97bb-7a4e69e81da3","topicName":"Sinusitis","slug":"sinusitis","lastRevised":"Last revised in June 2018","chapters":[{"id":"2e4afda1-e9d5-5296-a027-01f4617ab6d0","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"405b3d6d-e395-5fea-bc5e-02ddf80a8bd2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"22d307e8-3756-562c-b49a-55d20a9d0c5d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"36290f8d-5730-5655-8fa4-0d3f584a2980","slug":"changes","fullItemName":"Changes"},{"id":"b0ba5cc8-0ed6-52d6-86c5-12833f47d8d3","slug":"update","fullItemName":"Update"}]},{"id":"f730377b-2158-527d-b9a1-e99c0653afd0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"5f96218a-0038-5b66-8c21-7db2d19f37b7","slug":"goals","fullItemName":"Goals"},{"id":"f4318fc5-fa1f-52cc-964f-2eeb9d4f7a27","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"5a355772-1fc0-5033-929c-388a6956d7f5","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"41d933ba-5f60-5f51-9a18-8d60f08747d9","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"de2c52a0-2248-5977-a8e4-e495835a4f71","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"87fd2967-db43-5938-a83c-4761cd508da1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"6b9273f7-5c2c-5994-a3d4-8617be04677e","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"62fda2cc-020c-5dda-8886-be553f1b04bc","slug":"definition","fullItemName":"Definition"},{"id":"d0ca7ab5-8889-52dd-8ac6-bcf949adf403","slug":"causes","fullItemName":"Causes"},{"id":"6c331f3e-5cee-537d-9ff6-41dba5324ae1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2b91bcbf-5ce3-5cdb-bb8d-03f4297a60fc","slug":"complications","fullItemName":"Complications"}]},{"id":"17787dc5-901a-5bd4-93f1-b3bd7830f0a8","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"a3d013cf-b195-59ed-ac16-d0dc956a2637","slug":"diagnosis-acute-sinusitis","fullItemName":"Diagnosis - acute sinusitis"},{"id":"35be5a2e-61f3-5478-b238-c91020678ab0","slug":"diagnosis-chronic-sinusitis","fullItemName":"Diagnosis - chronic sinusitis"},{"id":"3ec7ffd9-5556-5eb7-9e51-14b4e1403c11","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"a5e0292f-f277-5859-bf17-fe0b4557eae3","fullItemName":"Management","slug":"management","subChapters":[{"id":"851420e1-952f-58e9-bb2d-b69ed5134584","slug":"acute-sinusitis","fullItemName":"Scenario: Acute sinusitis"},{"id":"fe33ee40-93d8-59ba-b62a-2f9ccc74cc63","slug":"chronic-sinusitis","fullItemName":"Scenario: Chronic sinusitis"}]},{"id":"ccbcf182-fe04-59e6-abdc-75557dc3c700","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"bc9974c3-e759-5746-8c96-b4538af16946","slug":"analgesia","fullItemName":"Analgesia"},{"id":"b7e24d48-87af-5f2c-9097-f4e3b1de894d","slug":"nasal-corticosteroids","fullItemName":"Nasal corticosteroids"},{"id":"5f63c8f8-0eaa-5fe0-b473-2d5e3aef00d1","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"0d802baf-8d25-5d8a-9c6d-b2a448983e4a","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"e874a37b-5cc8-58c8-9335-ac01e3b17271","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"bb4fef09-b30c-5637-ae85-ba203f26acd9","slug":"phenoxymethylpenicillin","fullItemName":"Phenoxymethylpenicillin"}]},{"id":"827f1e92-8727-5460-b9ae-00929701cc77","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4dbc93c2-6562-533b-8dd9-0891fc35822e","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8b0f7242-5fbb-5eb4-8b1a-13af5d4383df","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4a3d9d72-ed21-52d6-ba45-abcfb27ec6b4","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1b69a1e4-ec7f-5483-873c-2bb4bfb1345c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f04034ff-dd83-5bf5-83de-77fe9877df85","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f54f59b3-2893-5e4b-8dd2-3bee521cb237","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"164a0943-7f01-50bd-8c8f-a3695b72b662","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"6b9273f7-5c2c-5994-a3d4-8617be04677e","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}